EUVIMEDEUVIMED entdecken
Open Access

Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling

Wei-Chun Chou iD, Zhoumeng Lin iD

Toxicological Sciences · 31.01.2023 · 191 (1) · 1-14

DOI: 10.1093/toxsci/kfac101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 26.09.2022. Verfasst von Wei-Chun Chou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Development. Die Arbeit wurde bisher 202-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, The United States Department of Agriculture, National Institute of Food and Agriculture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Physiologically based pharmacokinetic (PBPK) models are useful tools in drug development and risk assessment of environmental chemicals. PBPK model development requires the collection of species-specific physiological, and chemical-specific absorption, distribution, metabolism, and excretion (ADME) parameters, which can be a time-consuming and expensive process. This raises a need to create computational models capable of predicting input parameter values for PBPK models, especially for new compounds. In this review, we summarize an emerging paradigm for integrating PBPK modeling with machine learning (ML) or artificial intelligence (AI)-based computational methods. This paradigm includes 3 steps (1) obtain time-concentration PK data and/or ADME parameters from publicly available databases, (2) develop ML/AI-based approaches to predict ADME parameters, and (3) incorporate the ML/AI models into PBPK models to predict PK summary statistics (eg, area under the curve and maximum plasma concentration). We also discuss a neural network architecture “neural ordinary differential equation (Neural-ODE)” that is capable of providing better predictive capabilities than other ML methods when used to directly predict time-series PK profiles. In order to support applications of ML/AI methods for PBPK model development, several challenges should be addressed (1) as more data become available, it is important to expand the training set by including the structural diversity of compounds to improve the prediction accuracy of ML/AI models; (2) due to the black box nature of many ML models, lack of sufficient interpretability is a limitation; (3) Neural-ODE has great potential to be used to generate time-series PK profiles for new compounds with limited ADME information, but its application remains to be explored. Despite existing challenges, ML/AI approaches will continue to facilitate the efficient development of robust PBPK models for a large number of chemicals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDrug DevelopmentMachine LearningModels, BiologicalNeural Networks, ComputerRisk Assessment

Stichwörter der Autor:innen

in vitro to in vivo extrapolation (IVIVE)artificial intelligencemachine learningpharmacometricsphysiologically based pharmacokinetic (PBPK) modelingrisk assessment

Autor:innen und Institutionen

  • Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, USA.
  • Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL 32608, USA.

ORCID-Profile: Wei-Chun Chou, Zhoumeng Lin

Förderung

  • NIBIB NIH HHS
  • The United States Department of Agriculture
  • National Institute of Food and Agriculture
  • Food Animal Residue Avoidance Databank
  • United States National Institutes of Health
  • NIH
  • National Institute of Biomedical Imaging and Bioengineering
  • NIBIB

Zitieren

APA

Chou, W. C., & Lin, Z. (2023). Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling. Toxicological Sciences, 191(1), 1-14. https://doi.org/10.1093/toxsci/kfac101

Vancouver

Chou WC, Lin Z. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling. Toxicological Sciences. 2023;191(1):1-14. doi:10.1093/toxsci/kfac101

BibTeX
@article{Chou2023,
  author = {Chou, Wei-Chun and Lin, Zhoumeng},
  title = {Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling},
  journal = {Toxicological Sciences},
  year = {2023},
  volume = {191},
  number = {1},
  pages = {1--14},
  doi = {10.1093/toxsci/kfac101}
}
Kostenlos starten →